QuidelOrtho Reports First Quarter 2025 Financial Results
May 08, 2025
May 08, 2025
SAN DIEGO, California, May 8 -- Quidel Corp., a provider of in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, issued the following news release:
* * *
QuidelOrtho Reports First Quarter 2025 Financial Results
- Total revenue of $693 million, growth of 5% as reported and 6% in constant currency, excluding COVID-19 and Donor Screening -
- Strong execution on cost-savings initiatives drivi . . .
* * *
QuidelOrtho Reports First Quarter 2025 Financial Results
- Total revenue of $693 million, growth of 5% as reported and 6% in constant currency, excluding COVID-19 and Donor Screening -
- Strong execution on cost-savings initiatives drivi . . .